Amy N. Allen

1.0k total citations
11 papers, 781 citations indexed

About

Amy N. Allen is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Amy N. Allen has authored 11 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Neurology. Recurrent topics in Amy N. Allen's work include Melanoma and MAPK Pathways (4 papers), Cancer Mechanisms and Therapy (3 papers) and T-cell and B-cell Immunology (3 papers). Amy N. Allen is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Cancer Mechanisms and Therapy (3 papers) and T-cell and B-cell Immunology (3 papers). Amy N. Allen collaborates with scholars based in United States and Taiwan. Amy N. Allen's co-authors include Jonathan D. Powell, Michael A. Lutz, Maureen R. Horton, M. Safford, Yan Zheng, Samuel L. Collins, Paul E. Zarek, Thomas P. Kole, Samuel L. Collins and Charles G. Drake and has published in prestigious journals such as Nature Immunology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Amy N. Allen

11 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy N. Allen United States	9	440	342	170	73	58	11	781
Andrew Shih United States	15	344 0.8×	211 0.6×	174 1.0×	80 1.1×	82 1.4×	34	694
Jonas Ungerbäck Sweden	18	426 1.0×	534 1.6×	209 1.2×	129 1.8×	72 1.2×	30	978
Rita Bisogni Italy	14	239 0.5×	502 1.5×	192 1.1×	167 2.3×	62 1.1×	25	868
Kimberly A. Solomon United States	16	189 0.4×	358 1.0×	230 1.4×	147 2.0×	37 0.6×	20	880
Chuen-Miin Leu Taiwan	11	459 1.0×	251 0.7×	150 0.9×	138 1.9×	50 0.9×	13	798
Angelo Messina Italy	16	237 0.5×	258 0.8×	402 2.4×	46 0.6×	96 1.7×	26	773
Nicholas C. Hsu Taiwan	15	272 0.6×	317 0.9×	236 1.4×	123 1.7×	61 1.1×	28	815
Habib Sadeghirad Australia	7	298 0.7×	238 0.7×	509 3.0×	82 1.1×	40 0.7×	14	837
John Dulos Netherlands	14	259 0.6×	196 0.6×	300 1.8×	35 0.5×	30 0.5×	22	673
Léa Tourneur France	14	318 0.7×	472 1.4×	225 1.3×	117 1.6×	55 0.9×	20	744

Countries citing papers authored by Amy N. Allen

Since Specialization

Citations

This map shows the geographic impact of Amy N. Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy N. Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy N. Allen more than expected).

Fields of papers citing papers by Amy N. Allen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy N. Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy N. Allen. The network helps show where Amy N. Allen may publish in the future.

Co-authorship network of co-authors of Amy N. Allen

This figure shows the co-authorship network connecting the top 25 collaborators of Amy N. Allen. A scholar is included among the top collaborators of Amy N. Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy N. Allen. Amy N. Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Yohe, Marielle E., Kai Pollard, Angelina V. Vaseva, et al.. (2022). Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma. Oncogene. 41(21). 2973–2983. 28 indexed citations

Wang, Jiawan, Kai Pollard, Amy N. Allen, et al.. (2020). Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors. Cancer Research. 80(23). 5367–5379. 41 indexed citations

Schreck, Karisa C., Amy N. Allen, Jiawan Wang, & Christine A. Pratilas. (2020). Combination MEK and mTOR inhibitor therapy is active in models of glioblastoma. Neuro-Oncology Advances. 2(1). vdaa138–vdaa138. 24 indexed citations

Allen, Amy N., Alice Can Ran Qin, Nitya Raj, et al.. (2019). Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition. PLoS ONE. 14(6). e0217399–e0217399. 13 indexed citations

Wang, Jiawan, Zhan Yao, Philip Jonsson, et al.. (2018). A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAF V600E-Mutant Brain Tumor. Cancer Discovery. 8(9). 1130–1141. 49 indexed citations

Wang, Jiawan, Zhan Yao, Philip Jonsson, et al.. (2018). Abstract 3184: A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF V600E-mutant brain tumor. Cancer Research. 78(13_Supplement). 3184–3184. 1 indexed citations

Allen, Amy N.. (2014). BIOPSYCHOSOCIAL PATHWAYS LINKING FOOD INSECURITY TO CARDIOVASCULAR DISEASE RISK: THE ROLE OF RACE, NEGATIVE AFFECTIVITY, AND DIET QUALITY. Digital Repository at the University of Maryland (University of Maryland College Park). 1 indexed citations

Brewer, LaPrincess C., et al.. (2013). Association of Race Consciousness With the Patient-Physician Relationship, Medication Adherence, and Blood Pressure in Urban Primary Care Patients. American Journal of Hypertension. 26(11). 1346–1352. 26 indexed citations

Zheng, Yan, Samuel L. Collins, Michael A. Lutz, et al.. (2007). A Role for Mammalian Target of Rapamycin in Regulating T Cell Activation versus Anergy. The Journal of Immunology. 178(4). 2163–2170. 222 indexed citations

10.

Safford, M., Samuel L. Collins, Michael A. Lutz, et al.. (2005). Egr-2 and Egr-3 are negative regulators of T cell activation. Nature Immunology. 6(5). 472–480. 334 indexed citations

11.

Allen, Amy N., Yan Zheng, Lawrence B. Gardner, et al.. (2004). The Novel Cyclophilin Binding Compound, Sanglifehrin A, Disassociates G1 Cell Cycle Arrest from Tolerance Induction. The Journal of Immunology. 172(8). 4797–4803. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact